Convergent Mechanisms Underlying Reprometabolic Syndrome in Women

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

Infertility, FemaleObesity

Interventions

DRUG

Estradiol Patches

Estradiol patched will be worn for 7 days.

Trial Locations (2)

NOT_YET_RECRUITING

University of Colorado School of Medicine, Aurora

RECRUITING

University of Colorado-School of Medicine, Aurora

All Listed Sponsors

collaborator

Colorado Clinical & Translational Sciences Institute

OTHER

lead

University of Colorado, Denver

OTHER

NCT06686537 - Convergent Mechanisms Underlying Reprometabolic Syndrome in Women | Biotech Hunter | Biotech Hunter